Detalhe da pesquisa
1.
Bis(Disulfide)-Bridged Somatostatin-14 Analogs and Their [111In]In-Radioligands: Synthesis and Preclinical Profile.
Int J Mol Sci
; 25(3)2024 Feb 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38339198
2.
Side-Chain Modified [99mTc]Tc-DT1 Mimics: A Comparative Study in NTS1R-Positive Models.
Int J Mol Sci
; 24(21)2023 Oct 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-37958525
3.
A novel definition and treatment of hyperinflammation in COVID-19 based on purinergic signalling.
Purinergic Signal
; 18(1): 13-59, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34757513
4.
177Lu-Dotatate plus long-acting octreotide versus highdose long-acting octreotide in patients with midgut neuroendocrine tumours (NETTER-1): final overall survival and long-term safety results from an open-label, randomised, controlled, phase 3 trial.
Lancet Oncol
; 22(12): 1752-1763, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34793718
5.
Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors.
N Engl J Med
; 376(2): 125-135, 2017 01 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-28076709
6.
PRRT neuroendocrine tumor response monitored using circulating transcript analysis: the NETest.
Eur J Nucl Med Mol Imaging
; 47(4): 895-906, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31838581
7.
Impact of liver tumour burden, alkaline phosphatase elevation, and target lesion size on treatment outcomes with 177Lu-Dotatate: an analysis of the NETTER-1 study.
Eur J Nucl Med Mol Imaging
; 47(10): 2372-2382, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32123969
8.
Optimizing the Profile of [99mTc]Tc-NT(7-13) Tracers in Pancreatic Cancer Models by Means of Protease Inhibitors.
Int J Mol Sci
; 21(21)2020 Oct 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-33114537
9.
[99mTc]Tc-DB1 Mimics with Different-Length PEG Spacers: Preclinical Comparison in GRPR-Positive Models.
Molecules
; 25(15)2020 Jul 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-32731473
10.
Unmet Medical Needs in Metastatic Lung and Digestive Neuroendocrine Neoplasms.
Neuroendocrinology
; 108(1): 18-25, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30153686
11.
Comparative evaluation of the new GRPR-antagonist 111 In-SB9 and 111 In-AMBA in prostate cancer models: Implications of in vivo stability.
J Labelled Comp Radiopharm
; 62(10): 646-655, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30963606
12.
Comparing Gly11/dAla11-Replacement vs. the in-Situ Neprilysin-Inhibition Approach on the Tumor-targeting Efficacy of the 111In-SB3/111In-SB4 Radiotracer Pair.
Molecules
; 24(6)2019 Mar 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-30871262
13.
Radiometal-Dependent Biological Profile of the Radiolabeled Gastrin-Releasing Peptide Receptor Antagonist SB3 in Cancer Theranostics: Metabolic and Biodistribution Patterns Defined by Neprilysin.
Bioconjug Chem
; 29(5): 1774-1784, 2018 05 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-29664606
14.
PRRT genomic signature in blood for prediction of 177Lu-octreotate efficacy.
Eur J Nucl Med Mol Imaging
; 45(7): 1155-1169, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29484451
15.
Preclinical and first clinical experience with the gastrin-releasing peptide receptor-antagonist [68Ga]SB3 and PET/CT.
Eur J Nucl Med Mol Imaging
; 43(5): 964-973, 2016 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-26631238
16.
Nephrotoxicity after PRRT with (177)Lu-DOTA-octreotate.
Eur J Nucl Med Mol Imaging
; 43(10): 1802-11, 2016 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-27160225
17.
Subacute haematotoxicity after PRRT with (177)Lu-DOTA-octreotate: prognostic factors, incidence and course.
Eur J Nucl Med Mol Imaging
; 43(3): 453-63, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26419852
18.
177Lu-Dotatate for Midgut Neuroendocrine Tumors
N Engl J Med
; 376(14): 1391-2, 2017 04 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28379808
19.
Long-term tolerability of PRRT in 807 patients with neuroendocrine tumours: the value and limitations of clinical factors.
Eur J Nucl Med Mol Imaging
; 42(1): 5-19, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25273832
20.
Hypocalcaemia after treatment with [177Lu-DOTA 0,Tyr3]octreotate.
Eur J Nucl Med Mol Imaging
; 40(12): 1843-52, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-23877632